Prostatis Group’s State Street SPDR Bloomberg 1-3 Month T-Bill ETF BIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Sell
49,153
-5,610
-10% -$513K 1.15% 18
2025
Q4
$5M Buy
54,763
+26,390
+93% +$2.42M 1.19% 18
2025
Q3
$2.6M Sell
28,373
-5,246
-16% -$481K 0.65% 43
2025
Q2
$3.08M Sell
33,619
-410,478
-92% -$37.6M 0.88% 32
2025
Q1
$40.7M Buy
444,097
+266,027
+149% +$24.4M 12.85% 1
2024
Q4
$16.3M Sell
178,070
-166,363
-48% -$15.2M 4.75% 3
2024
Q3
$31.6M Buy
344,433
+331,455
+2,554% +$30.4M 10.35% 2
2024
Q2
$1.24M Sell
12,978
-37,914
-74% -$3.47M 0.43% 57
2024
Q1
$4.67M Sell
50,892
-8,139
-14% -$746K 1.77% 13
2023
Q4
$5.39M Sell
59,031
-190,269
-76% -$17.4M 2.26% 12
2023
Q3
$22.9M Buy
+249,300
New +$22.8M 11.21% 1

Other funds holding BIL

Prostatis Group's BIL Position: Q1 2026 in Review

Prostatis Group reduced its State Street SPDR Bloomberg 1-3 Month T-Bill ETF (BIL) stake by 10% in Q1 2026, selling an estimated $513K and leaving 49,153 shares worth $4.5M. The position accounts for 1.15% of the portfolio, ranked #18.

Prostatis Group first reported a position in BIL in Q3 2023 and has held it in 11 quarters since. The position peaked at $40.7M in Q1 2025. 1,309 funds tracked by Wall St. Rank hold BIL as of Q1 2026.

  • Prostatis Group held 49,153 shares of State Street SPDR Bloomberg 1-3 Month T-Bill ETF worth $4.5M as of Q1 2026.
  • Prostatis Group sold 5,610 State Street SPDR Bloomberg 1-3 Month T-Bill ETF shares in Q1 2026, an estimated $513K.
  • State Street SPDR Bloomberg 1-3 Month T-Bill ETF made up 1.15% of Prostatis Group's portfolio in Q1 2026, its #18 holding.
  • Prostatis Group first reported a position in State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q3 2023 and has held it in 11 quarters since.
  • Prostatis Group's State Street SPDR Bloomberg 1-3 Month T-Bill ETF position peaked at $40.7M in Q1 2025.
  • 1,309 funds tracked by Wall St. Rank held State Street SPDR Bloomberg 1-3 Month T-Bill ETF as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.